- Filed
- Mar 12, 2025 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q3 2025 · Mar 7, 2025 | 49.72M sh |
| Shares Diluted | Q3 2025 · Jan 31, 2025 | 52.64M sh |
| Shares Diluted | Q3 2025 · Jan 31, 2025 | 48.52M sh |
| Shares Diluted | Q3 2025 · Jan 31, 2024 | 34.72M sh |
| Shares Diluted | Q3 2025 · Jan 31, 2024 | 34.57M sh |
| Capex | Q3 2025 · Jan 31, 2025 | $153K |
| Capex | Q3 2025 · Jan 31, 2024 | $27K |
| Operating Cash Flow | Q3 2025 · Jan 31, 2025 | −$112.54M |
| Operating Cash Flow | Q3 2025 · Jan 31, 2024 | −$74.13M |
| Cash And Equivalents | Q3 2025 · Jan 31, 2025 | $167.29M |
| Cash And Equivalents | Q3 2025 · Apr 30, 2024 | $31.79M |
| Cash And Equivalents | Q3 2025 · Jan 31, 2024 | $23.06M |
| Stockholders Equity | Q3 2025 · Jan 31, 2025 | $145.13M |
| Stockholders Equity | Q3 2025 · Oct 31, 2024 | $133.99M |
| Stockholders Equity | Q3 2025 · Jul 31, 2024 | $172.8M |
| Stockholders Equity | Q3 2025 · Apr 30, 2024 | $206.58M |
| Stockholders Equity | Q3 2025 · Jan 31, 2024 | $88.58M |
| Stockholders Equity | Q3 2025 · Oct 31, 2023 | $114.45M |
| Stockholders Equity | Q3 2025 · Jul 31, 2023 | $139.34M |
| Stockholders Equity | Q3 2025 · Apr 30, 2023 | $161.03M |
| Current Liabilities | Q3 2025 · Jan 31, 2025 | $25.62M |
| Current Liabilities | Q3 2025 · Apr 30, 2024 | $22.81M |
| Current Assets | Q3 2025 · Jan 31, 2025 | $267.36M |
| Current Assets | Q3 2025 · Apr 30, 2024 | $225.69M |
| Total Assets | Q3 2025 · Jan 31, 2025 | $275.99M |
| Total Assets | Q3 2025 · Apr 30, 2024 | $235.4M |
| Eps Diluted | Q3 2025 · Jan 31, 2025 | −$0.92 |
| Eps Diluted | Q3 2025 · Jan 31, 2025 | −$2.70 |
| Eps Diluted | Q3 2025 · Jan 31, 2024 | −$0.84 |
| Eps Diluted | Q3 2025 · Jan 31, 2024 | −$2.37 |
| Eps Basic | Q3 2025 · Jan 31, 2025 | −$0.92 |
| Eps Basic | Q3 2025 · Jan 31, 2025 | −$2.70 |
| Eps Basic | Q3 2025 · Jan 31, 2024 | −$0.84 |
| Eps Basic | Q3 2025 · Jan 31, 2024 | −$2.37 |
| Rd Expense | Q3 2025 · Jan 31, 2025 | $12.59M |
| Rd Expense | Q3 2025 · Jan 31, 2025 | $55.82M |
| Rd Expense | Q3 2025 · Jan 31, 2024 | $22.52M |
| Rd Expense | Q3 2025 · Jan 31, 2024 | $60.92M |
| Net Income | Q3 2025 · Jan 31, 2025 | −$48.51M |
| Net Income | Q3 2025 · Jan 31, 2025 | −$131.22M |
| Net Income | Q3 2025 · Oct 31, 2024 | −$42.27M |
| Net Income | Q3 2025 · Jul 31, 2024 | −$40.44M |
| Net Income | Q3 2025 · Jan 31, 2024 | −$29.03M |
| Net Income | Q3 2025 · Jan 31, 2024 | −$82M |
| Net Income | Q3 2025 · Oct 31, 2023 | −$27.65M |
| Net Income | Q3 2025 · Jul 31, 2023 | −$25.32M |
| Operating Income | Q3 2025 · Jan 31, 2025 | −$42.94M |
| Operating Income | Q3 2025 · Jan 31, 2025 | −$132.97M |
| Operating Income | Q3 2025 · Jan 31, 2024 | −$33.15M |
| Operating Income | Q3 2025 · Jan 31, 2024 | −$91.99M |